1 – 19 of 19
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia : data from the PedNet cohort
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
- 2023
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
(
- Contribution to journal › Article
- 2022
-
Mark
Bone mineral density in haemophilia – a multicentre study evaluating the impact of different replacement regimens
(
- Contribution to journal › Article
-
Mark
Long-term joint outcomes in adolescents with moderate or severe haemophilia A
(
- Contribution to journal › Article
- 2021
-
Mark
Haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
(
- Contribution to journal › Article
- 2020
-
Mark
Novel F8 and F9 gene variants from the PedNet Hemophilia Registry classified according to ACMG/AMP guidelines
(
- Contribution to journal › Article
-
Mark
Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis
(
- Contribution to journal › Article
- 2019
-
Mark
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia : A comparison between intermediate- and high-dose prophylaxis
(
- Contribution to journal › Article
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
- 2017
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
-
Mark
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors
(
- Contribution to journal › Article
- 2016
-
Mark
Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
(
- Contribution to journal › Scientific review
-
Mark
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors
(
- Contribution to journal › Article
- 2015
-
Mark
Targeting Factor Replacement Therapy in Severe Hemophilia: Which Level Is Important?
(
- Contribution to journal › Article
-
Mark
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
(
- Contribution to journal › Letter
- 2013
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
(
- Contribution to journal › Article
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
- 2012
-
Mark
Models of prophylaxis.
(
- Contribution to journal › Article